These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation. Shigematsu A; Yasumoto A; Yamamoto S; Sugita J; Kondo T; Onozawa M; Kahata K; Endo T; Ota S; Sato N; Takahata M; Okada K; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M Biol Blood Marrow Transplant; 2009 Jun; 15(6):679-85. PubMed ID: 19450752 [TBL] [Abstract][Full Text] [Related]
50. Central serous chorioretinopathy after solid organ transplantation. Fawzi AA; Holland GN; Kreiger AE; Heckenlively JR; Arroyo JG; Cunningham ET Ophthalmology; 2006 May; 113(5):805-13.e5. PubMed ID: 16650676 [TBL] [Abstract][Full Text] [Related]
51. BK virus nephropathy after allogeneic stem cell transplantation: a case report and literature review. Lekakis LJ; Macrinici V; Baraboutis IG; Mitchell B; Howard DS Am J Hematol; 2009 Apr; 84(4):243-6. PubMed ID: 19208419 [TBL] [Abstract][Full Text] [Related]
52. Coccidioidomycosis in patients who have undergone transplantation. Blair JE Ann N Y Acad Sci; 2007 Sep; 1111():365-76. PubMed ID: 17363431 [TBL] [Abstract][Full Text] [Related]
53. Retinal complications in patients with solid organ or bone marrow transplantations. Chung H; Kim KH; Kim JG; Lee SY; Yoon YH Transplantation; 2007 Mar; 83(6):694-9. PubMed ID: 17414700 [TBL] [Abstract][Full Text] [Related]
54. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center. Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438 [TBL] [Abstract][Full Text] [Related]
55. Ocular Myasthenia Gravis treatment: the case against prednisone therapy and thymectomy. Gilbert ME; De Sousa EA; Savino PJ Arch Neurol; 2007 Dec; 64(12):1790-2. PubMed ID: 18071047 [No Abstract] [Full Text] [Related]
56. Tapping our immune potential to realise the ultimate goal. The Lancet Oncology Lancet Oncol; 2011 Dec; 12(13):1175. PubMed ID: 22123589 [No Abstract] [Full Text] [Related]
57. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation. Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991 [TBL] [Abstract][Full Text] [Related]
58. [Post-transplantation diabetes mellitus and its association with current immunodepressants]. Rivera Valbuena JA; Zugasti Murillo A; Jara Albarrán A Med Clin (Barc); 2001 Sep; 117(9):353-6. PubMed ID: 11749909 [No Abstract] [Full Text] [Related]
59. Current world literature. Curr Opin Organ Transplant; 2009 Dec; 14(6):701-13. PubMed ID: 19920763 [No Abstract] [Full Text] [Related]
60. Cancers complicating organ transplantation. Penn I N Engl J Med; 1990 Dec; 323(25):1767-9. PubMed ID: 2247108 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]